stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Pierre Fabre SA

France · Privately owned

Pierre Fabre is a French company that makes and sells medicines, skin-care products, and health and beauty brands sold in pharmacies.

Pierre Fabre is a French health and beauty company. It makes prescription medicines, over-the-counter drugs, and skin-care products, and it sells many of its consumer brands through pharmacies rather than supermarkets. If you have ever bought a tube of Eau Thermale Avène cream for sensitive skin or a Klorane shampoo, you have handed money to Pierre Fabre.

Pierre Fabre (PIERRE-FABRE) Eau Thermale Avène dermo-cosmetics: line art illustration of Eau Thermale Avène skincare tube with its blue branding and thermal spring water droplet motif
Eau Thermale Avène
Avène creams use thermal spring water from a French spa town.

The company is really two businesses under one roof. The pharmaceutical side develops and sells medicines, with a strong focus on oncology (cancer) and dermatology, and it also makes products that pharmacists sell without a prescription. The consumer side owns well-known pharmacy brands, including Avène, Klorane, Ducray, and René Furterer, which cover skin care, hair care, and sun protection. Pharmacists are the gatekeepers: Pierre Fabre's products sit on pharmacy shelves, and customers often come in asking for them by name, which is why the company invests heavily in building brands that pharmacists trust and recommend. What makes Pierre Fabre unusual is its ownership. It is not listed on a stock exchange. A public-benefit foundation controls the company, and the founding Fabre family has a stake, so it answers to a long-term mission rather than to Wall Street's quarterly demands. The company was founded in 1962 by Pierre Fabre, a pharmacist from southern France, and it grew from a small pharmacy business into a global group headquartered in Castres, with products sold in well over a hundred countries.


Its main strength is the pharmacy channel and the loyalty of pharmacists and customers to brands like Avène. Its main vulnerability is that this channel is crowded. Big rivals such as L'Oréal (which owns La Roche-Posay and Vichy), Johnson & Johnson (which owns Neutrogena and Aveeno), and Bayer all fight for the same pharmacy shelf space and the same sensitive-skin shopper. Pierre Fabre stays competitive by pouring money into dermatology research and clinical testing, which lets it claim its products are backed by science — a claim that matters a lot in the skin-care aisle.

Saved answer · last researched 10 Nov 2026